Impact of a high-dose nitrate strategy on cardiac stress in acute heart failure: A pilot study: Original Article

Journal of Internal Medicine

Volumn 267, Issue 3, 2010, Pages 322-330

  Breidthardt, T ^a   Noveanu, M ^a   Potocki, M ^a   Reichlin, T ^a   Egli, P ^a   Hartwiger, S ^a   Socrates, T ^a   Gayat, E ^b   Christ, M ^a,c   Mebazaa, A ^a,b   Mueller, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

Acute heart failure; B type natriuretic peptide; Pre and afterload lowering

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; FUROSEMIDE; GLYCERYL TRINITRATE; NITRATE; TROPONIN T;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HEART STRESS; HUMAN; INTENSIVE CARE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ADMINISTRATION, SUBLINGUAL; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NITRATES; PILOT PROJECTS; PROSPECTIVE STUDIES;

EID: 75749090795     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02146.x     Document Type: Article

References (26)

1. De Luca L, Fonarow GC, Adams KF Jr. et al. Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Fail Rev 2007 12 : 97 104. (Pubitemid 46916954)
2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008 29 : 2388 2442.
3. Komajda M, Follath F, Swedberg K et al. The EuroHeart Failure Survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 2003 24 : 464 474. (Pubitemid 36286188)
4. Fonarow GC, Corday E. Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry. Heart Fail Rev 2004 9 : 179 185.
5. Cotter G, Metzkor E, Kaluski E et al. Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema. Lancet 1998 351 : 389 393.
6. Sharon A, Shpirer I, Kaluski E et al. High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema. J Am Coll Cardiol 2000 36 : 832 837.
7. Khot UN, Novaro GM, Popovic ZB et al. Nitroprusside in critically ill patients with left ventricular dysfunction and aortic stenosis. N Engl J Med 2003 348 : 1756 1763.
8. Taylor AL, Ziesche S, Yancy C et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004 351 : 2049 2057.
9. Mueller C, Breidthardt T, Laule-Kilian K, Christ M, Perruchoud AP. The intergration of BNP and NT-proBNP into clinical medicine. Swiss Med Wkly 2007 137 : 4 12.
10. Kazanegra R, Cheng V, Garcia A et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail 2001 7 : 21 9.
11. Bettencourt P, Azevedo A, Pimenta J, Frioes F, Ferreira S, Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 2004 110 : 2168 2174.
12. Logeart D, Thabut G, Jourdain P et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004 43 : 635 641.
13. Verdiani V, Nozzoli C, Bacci F et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 2005 7 : 566 571.
14. Nieminen MS, Bohm M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005 26 : 384 416. (Pubitemid 40283098)
15. Swedberg K, Cleland J, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005 26 : 1115 1140.
16. Kellum JA, Bellomo R, Ronco C. The concept of acute kidney injury and the RIFLE criteria. Contrib Nephrol 2007 156 : 10 6.
17. Paulus WJ, Tschope C, Sanderson JE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 28 : 2539 2550.
18. Elkayam U. Nitrates in the treatment of congestive heart failure. Am J Cardiol 1996 77 : 41C 51C.
19. Packer M, Medina N, Yushak M, Lee WH. Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study. Am Heart J 1985 109 : 1293 1299.
20. Elkayam U, Roth A, Kumar A et al. Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation. Am J Cardiol 1987 60 : 1106 1111. (Pubitemid 17164604)
21. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 1987 317 : 799 804. (Pubitemid 17136471)
22. Roth A, Kulick D, Freidenberger L, Hong R, Rahimtoola SH, Elkayam U. Early tolerance to hemodynamic effects of high dose transdermal nitroglycerin in responders with severe chronic heart failure. J Am Coll Cardiol 1987 9 : 858 864. (Pubitemid 17044932)
23. Anand IS, Tam SW, Rector TS et al. Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure Trial. J Am Coll Cardiol 2007 49 : 32 9.
24. Breidthardt T, Mebazaa A, Mueller C. Predicting progression in nondiabetic kidney disease: the importance of cardiorenal interactions. Kidney Int 2009 75 : 253 255.
25. Fonarow GC, Adams KF Jr., Abraham WT, Yancy CW, Boscardin WJ. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005 293 : 572 580.
26. Peacock WFt, De Marco T, Fonarow GC et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008 358 : 2117 2126.